<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01065961</url>
  </required_header>
  <id_info>
    <org_study_id>D-01</org_study_id>
    <nct_id>NCT01065961</nct_id>
  </id_info>
  <brief_title>Randomized Controlled Trials of the Effects of Decadron on Swallowing, Airway, and Arthrodesis</brief_title>
  <official_title>Prospective Randomized Controlled Trail of the Effects of Steroids on Swallowing, Airway and Arthrodesis Related to Myulti-Level Anterior Cervical Reconstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Albany Medical College</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Albany Medical College</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anterior cervical discectomy and fusion with or without decompression is a well-established
      surgical treatment for spine patients with the appropriate indications. Anterior approach
      involves some retraction that affect the midline structures of the anterior neck. Irritation
      and swelling may result, leading to postoperative dysphagia and the less common but
      critically important occurrence of postoperative airway compromise. Steroids given
      intraoperatively may reduce the incidence of these adverse outcomes by reducing the degree of
      swelling within the anterior neck subsequent to local surgical tissue trauma.

      The investigators hypothesize that the use of steroids intraoperatively provides a
      significant benefit to the patient, in terms of reduced incidence of dysphagia and airway
      compromise.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2008</start_date>
  <completion_date type="Anticipated">November 2016</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>subjects will demonstrate good bony fusion</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Swallowing</condition>
  <arm_group>
    <arm_group_label>Decadron</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subject will be given Decadron 0.2mg/kg intraoperatively. This dose will be followed by 4 mg. every 6 hours for the first 24 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>subject will be given a blinded dose of placebo saline intraoperatively followed by placebo doses every 6 hours for 24 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Decadron</intervention_name>
    <description>Decadron will be given at a dose of 0.2 mg/kg intraoperatively, followed by Decadron 4 mg. every 6 hours for 24 hours.</description>
    <arm_group_label>Decadron</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Placebo saline will be given intraoperatively as well as 4 doses every 6 hours for 24 hours.</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or greater

          -  Cervical spondylosis requiring surgical treatment at 2 or more motion segments

          -  Ventrally - approachable vertebral levels

        Exclusion Criteria:

          -  Minors (under 18 years old)

          -  Pregnant women

          -  Patients currently taking steroids

          -  Patients requiring surgical treatment at only one segment

          -  Comatose or incapacitated patients who cannot consent to participate

          -  Wards of the state

          -  Persons with an allergy to dexamethasone or related drugs

          -  Persons employed at Albany Medical Center
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Darryl DiRisio, MD</last_name>
    <phone>518 262-5088</phone>
    <email>dirisi@mail.amc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Margaret Czerwinski, BSN, RN</last_name>
    <phone>518 262-0034</phone>
    <email>czerwim@mail.amc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Albany Medical Center</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2010</study_first_submitted>
  <study_first_submitted_qc>February 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2010</study_first_posted>
  <last_update_submitted>February 9, 2010</last_update_submitted>
  <last_update_submitted_qc>February 9, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 10, 2010</last_update_posted>
  <responsible_party>
    <name_title>Darryl DiRisio, MD</name_title>
    <organization>Albany Medical Center</organization>
  </responsible_party>
  <keyword>anterior</keyword>
  <keyword>cervical</keyword>
  <keyword>fusion</keyword>
  <keyword>swallowing</keyword>
  <keyword>Swallowing after anterior cervical discectomy and fusion</keyword>
  <keyword>Bony fusion rates post anterior cervical discectomy and fusion</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

